Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cresco Labs (CRLBF) EBITDA Margin (2020 - 2026)

Cresco Labs filings provide 7 years of EBITDA Margin readings, the most recent being 7.38% for Q1 2026.

  • On a quarterly basis, EBITDA Margin fell 81.0% to 7.38% in Q1 2026 year-over-year; TTM through Mar 2026 was 4.74%, a 1773.0% decrease, with the full-year FY2025 number at 21.26%, down 1084.0% from a year prior.
  • EBITDA Margin hit 7.38% in Q1 2026 for Cresco Labs, up from 46.76% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 17.56% in Q2 2024 to a low of 71.89% in Q4 2022.
  • Median EBITDA Margin over the past 5 years was 9.45% (2022), compared with a mean of 2.44%.
  • The widest YoY moves for EBITDA Margin: up 13024bps in 2022, down -7903bps in 2022.
  • Cresco Labs' EBITDA Margin stood at 71.89% in 2022, then soared by 120bps to 14.4% in 2023, then decreased by -23bps to 11.03% in 2024, then crashed by -524bps to 46.76% in 2025, then soared by 116bps to 7.38% in 2026.
  • The last three reported values for EBITDA Margin were 7.38% (Q1 2026), 46.76% (Q4 2025), and 10.81% (Q3 2025) per Business Quant data.